Comparison
NMN vs Resveratrol
NMN
Nicotinamide mononucleotide — NAD+ precursor. Studied for cellular aging and metabolic health.
Resveratrol
Polyphenol from grape skins and Japanese knotweed. SIRT1 activator. Studied for longevity and cardiovascular health.
| Field | NMN | Resveratrol |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 250–1000mg | 250–500mg |
| Half-life | — | 9h |
| Onset | — | — |
| Evidence | EVIDENCEB | EVIDENCEB |
| Safety | ●●●●● | ●●●●● |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 600 | 16000 |
The comparison in plain English
Auto-generated from dataNMN and Resveratrol are both in the neuroprotective category respectively. NMN Nicotinamide mononucleotide — NAD+ precursor. Resveratrol Polyphenol from grape skins and Japanese knotweed.
Bottom line
NMN (evidence B, safety 5/5) matches the evidence base of Resveratrol (evidence B, safety 5/5). NMN has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose NMN if
NMN is the better fit when your goal aligns with its mechanism (Direct precursor to NAD+ — one biosynthetic step closer than nicotinamide riboside, bypassing the NRK1/NRK2 enzymatic step) and the dose range (250–1000mg) suits your protocol. Half-life is —h.
Choose Resveratrol if
Resveratrol is the better fit when your goal aligns with its mechanism (Activates SIRT1 (sirtuin 1), the longevity-associated histone deacetylase that mediates calorie restriction's lifespan extension in model organisms) and the dose range (250–500mg) suits your protocol. Half-life is 9h.